1 Though risk for cocaine use disorder, like most complex disease, is subject to considerable 2 inter-individual variation, the sources of that variation -including genetics and sex -are 3 frequently ignored in non-human animal studies. Here, we studied both males and females of 4 eight different inbred mouse strains whose reproducible genomes capture 90% of the genetic 5 diversity mice. In this population, individual differences explain a substantial proportion of 6 variance in important cocaine-related behavioral, physiological, and striatum transcriptional 7 responses traits. Individual differences thus represent a crucial source of biological information 8 about addiction mechanisms missing in typical studies. 9
Introduction
Addictions are a highly prevalent complex disease, leading to a public health crisis associated 11 with substantial morbidity and mortality. Illicit substance use disorders afflict 1 in 14 young 12 adults in the United States 1 and drug overdoses are now the leading cause of accidental death 13 among American adults under 55 2 . Genetic variation and sex differences are both known to 14 influence addiction vulnerability; cocaine use disorder is highly heritable (H 2 = 0.71) 3 and 15 substance use behaviors show sex differences in both humans and other animals 4,5 . 16
Consequently, the neurobiology underlying addiction cannot be understood completely without 17 consideration of genetic background and sex. 18
However, like many complex diseases, behavioral and genomic studies of addiction-related 19 phenotypes often utilize only males of a single inbred mouse strain 6 or outbred rat populations 20 confounded by vendor 7 . While these experimental methodologies certainly produce valuable 21 biological insights, ignoring sex differences and genetic variation limits their generalizability and 22 does not reduce experimental noise 8, 9 . Inclusion of genetic variability and both males and 23 females in rodent studies has the power to identify addiction-relevant targets, delineate 24 variants' effects on co-regulation and co-expression networks, and define druggable network 25 nodes. Rodent genetic variation does not capture precise human variants, but it can be 26 exploited to determine underlying mechanisms in addiction-relevant processes. As a further 27 benefit, genotypic and phenotypic precision allows genetics studies in rodents to be performed 28 at orders of magnitude lower cost than human GWAS. 29
To assess genetics, sex, and their interaction on cocaine-related phenotypes in mice, we 30 undertook a large-scale comprehensive evaluation of behavioral, physiological, and brain 31 transcriptomic measures in both male and female mice from the eight inbred founder strains of 32 the Diversity Outbred (DO) mouse heterogenous stock 10 . The genomes represented by these 33 strains capture approximately 90% of the genetic diversity in Mus musculus 11 . 34
Results

35
In the eight founder strains for the DO, we surveyed behavioral and physiological correlates of 36 future cocaine use -including multiple novelty response behaviors, circadian rhythm 37 phenotypes observed in cells, and reversal learning as a measure of reward learning and 38 impulsivity. We directly measured cocaine-related behaviors such as initial locomotor 39 sensitivity to cocaine and intravenous self-administration (IVSA) of cocaine. Finally, we 40 measured the striatum transcriptome response to cocaine in all eight founder strains with 41
RNAseq. Our work represents the first time that many of these behavioral, physiological, and 42 molecular traits have been studied using methods powered to detect sex and genotype effects 43 and the extent to which these interact by moderating one another. 44
Response to novelty predicts psychostimulant addiction-related phenotypes in both humans 12 45 and mice 13 . We first assessed differences in behavioral traits related to exploration and 46 Supplementary Table S1 ). Further, for the 48 phenotype of total nose pokes in the hole board, there was a significant sex difference (F1,597 = 49 10.69, p = 0.0014). We detected strain-by-sex interactions in the total number of hole board 50 nose pokes (F7,597 = 2.74, p = 0.0083) and in the proportion of distance traveled in the center of 51 the open field (F7,684 = 2.09, p = 0.043), indicating that sex differences in these novelty response 52 traits are moderated by genetic background. Total nose pokes in the hole board ( Figure 1A) and 53 novel place preference ( Figure 1B) showed the largest differences in wild-derived strains, 54 demonstrating the importance of their expanded phenotypic range 14 . Transitions between the 55 sides of the light-dark box also showed extreme phenotypes in wild-derived mouse strains 56 ( Figure 1D) . 57
Circadian rhythm and reward-related behavioral phenotypes are co-inherited and rhythm 58 disruptions are linked to development and progression of substance use disorders 15 . The 59 molecular clock system directly influences expression of dopamine receptors in the striatum 16 . 60
A cell-based assay on fibroblasts derived from each of the founder strains in which a Bmal1-61 dLuc reporter was utilized for circadian measurement of luciferase bioluminescence to assess 62 differences in circadian rhythmicity 17,18 . We found very high heritability of the amplitude of 63 these rhythmic patterns (H 2 = 0.59, Figure 1E ), but no significant sex differences or strain x sex 64 interactions. These results suggest that genetic differences in the molecular clock are one 65 potential mechanism for individual differences in addiction-related phenotypes. 66
Reversal learning tasks evaluate impulsive and compulsive behaviors that predict addiction 67 liability 19 . Within reversal learning paradigms, one measure of impulsivity is the number of 68 premature responses produced during the reversal phase of the task. Premature reversal 69 responses in these showed moderate heritability across this panel of mice (H 2 = 0.29, Figure  70 1F), but no significant sex differences or strain x sex interactions. We observed the lowest rate 71 of premature responding in the wild-derived PWK/PhJ strain. 72
We next sought to assess individual differences in initial locomotor response to cocaine, a 73 behavioral phenotype that predicts subsequent drug use in humans 20 . In these diverse mouse 74 strains, initial cocaine sensitivity showed strong heritability (H 2 = 0.48 for initial sensitivity, Figure 1G ). Wild-derived strains, particularly WSB/EiJ and PWK/PhJ, exhibited the highest initial sensitivity to cocaine. 77
Operant drug self-administration procedures directly quantify reinforced responding for drug 13 . 78
Heritability of cocaine IVSA traits in the founders of the DO was very strong (H 2 = 0.47 for 79 sessions to acquisition of IVSA; H 2 = 0.60 for total infusions at FR-1 1.0 mg/kg, Figure 1H -I). The 80 high heritability of infusions earned is quite similar to the observed heritability of human 81 cocaine use disorder 3 . Of note, 129S1/SvImJ mice do not acquire IVSA and do not take any 82 cocaine during the acquisition phase. The largest phenotypic range manifests in wild-derived 83 mice; PWK/PhJ mice acquire IVSA behavior very quickly and self-administer the most cocaine -84 about four times as much as C57BL/6J -while WSB/EiJ mice self-administer the least amount of 85 cocaine relative to the other strains that do acquire IVSA behavior. The broad phenotypic range 86 of volitional cocaine-taking behaviors in these genetically diverse mouse strains represents a 87 clear opportunity to study mechanisms underlying variation in the physiology of addiction. 88
Because addiction-related phenotypes are highly heritable and sometimes exhibit sex 89 differences in a manner dependent on genetics, we next sought to assess heritable differences 90 in the molecular response to cocaine. Male and female mice of the eight DO founder strains 91 were given multiple injections of cocaine or saline over 19 days. Samples for bulk RNAseq were 92 collected from striatum at least 24 hours after the final injection of repeated administration of 93 either cocaine or vehicle (sham). First, we documented that in the absence of cocaine, most 94 transcripts show moderate to high baseline heritability across the founder strains (median H 2 = 95 0.29) and that subspecies of origin explains the greatest amount of variation in expression 96 (Figure 2A) . Using a linear modeling approach 21,22 , we found few expression differences 97 attributable solely to the effect of cocaine treatment. Instead, significant effects of cocaine 98 arose in interaction with individual differences such as genetic background. The greatest 99 quantity of differentially expressed transcripts was observed in the strain-by-sex-by-drug 100 treatment three-way interaction (1,282 genes at q < 0.01, Figure 2B , Supplementary Table S2 ). 101 Some strains responded more strongly than others; 129S1/SvImJ and PWK/PhJ had many 102 expressed genes influenced by cocaine and sex-by-cocaine interactions (PWK/PhJ: 89 genes at q 103 < 0.01, Figure 2C ) while the commonly used C57BL/6J strain had very few (4 genes at q < 0.01, injection. These pharmacokinetic differences do not account for the strong differences between 131 strains such as 129S1/SvImJ and A/J, whose brain cocaine pharmacokinetic profiles are very 132 derived from production colonies at The Jackson Laboratory and breeders were replaced with 159 animals from The Jackson Laboratory's production colony at least every five generations. The either the Chesler Lab colonies or from production colonies in The Jackson Laboratory. The 162 studies described utilized a total of 1,085 mice ( Supplementary Table S3 ). Distance moved after injection on day 3 minus day 2 was uses as a measure of initial locomotor 228 sensitivity to cocaine. The sensitization study produced observations from a total of 230 mice. 229
Cocaine Intravenous Self-Administration
230
Prior to cocaine intravenous self-administration, mice were implanted with a jugular catheter 231 and allowed 10 days for post-operative recovery. In an operant conditioning paradigm, mice 232 were allowed to acquire cocaine self-administration at 1.0 mg/kg, then evaluated for dose-233 response effects at eight different doses. After a final stabilizing dose at 1.8 mg/kg, responses 234 during seven days of withdrawal were recorded. Finally, cued reinstatement was recorded for 235 two days. Self-administration in these eight mouse strains was performed according to v1.0 of 236 the CSNA's SOP (https://www.jax.org/-/media/jaxweb/files/research-and-faculty/tools-and-237 resources/system-neurogenetics/intravenous-self-administration-ivsa-238 paradigm.pdf?la=en&hash=FA64135F219C7DF65937A1CF9270301B0E771836). The 239 intravenous self-administration study produced observations from a total of 217 mice.
publication. 243
Heritability Calculations 244
For each trait, heritability was calculated from linear models using the isogenic strain as the 245 independent categorical variable using the following equation: For some traits such as number of infusions at FR-1 1.0 mg/kg cocaine self-administration, a 252 single strain such as 129S1/SvImJ showed little to no variation, which may upwardly bias 253 heritability calculations. For these traits, heritability was calculated both with and without the 254 low variance strain. The data reported in the paper rely upon the inclusive calculation, but 255 results of both methods of calculation are reported for completeness (see Supplementary  256   Table S1 ). We gratefully acknowledge Technologies service at The Jackson Laboratory Genome for their 328 expert assistance on the RNAseq experiment, Surgical Services at The Jackson Laboratory for 329 their work on the intravenous self-administration paradigm, and the NIDA Drug Supply for 330 providing cocaine. We would further like to thank Stephen Krasinski for critical reading and 331 comments during manuscript preparation, Rob Williams for helpful discussion on the analysis, 332 and C. Herbert Pratt for scientific program management. This work was funded by NIH P50 333 DA039841 (Center for Systems Neurogenetics of Addiction) to EJC, LMT, JDJ, RWL CAM, VMP, 334
LGR, and SJSR as well as NIH R01 DA037927 to EJC and K99 DA043573 to PED. 335
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